Dynamic and static biomechanical traits of cardiac fibrosis

Han Liu1,2, Pengbei Fan1,2, Fanli Jin1,2

  • 1Henan Key Laboratory of Chinese Medicine for Respiratory Disease, Academy of Chinese Medical Sciences, Henan University of Chinese Medicine, Zhengzhou, China.

Insights

This review explores how biomechanical factors like stretch and stiffness drive cardiac fibrosis, a major cause of heart disease. Understanding these mechanical forces is key to developing new treatments for this condition.

Area of Science:

  • Biomedical Engineering
  • Cardiovascular Research
  • Mechanobiology

Background:

  • Cardiac fibrosis is a significant factor in cardiovascular diseases, a leading global cause of death.
  • Biomechanical properties of fibrosis are increasingly recognized for their roles in cardiac fibrosis development, progression, and therapeutic strategies.

Purpose of the Study:

  • To review the distinct biomechanical traits influencing cardiac fibrosis.
  • To categorize these traits as static or dynamic based on cardiac characteristics.
  • To explore their effects, transduction mechanisms, and in vitro models for identifying therapeutic targets.

Main Methods:

  • Literature review focusing on biomechanical traits in cardiac fibrosis.
  • Categorization of biomechanical factors (stretch, fluid shear stress, ECM microarchitecture, ECM stiffness) into static and dynamic types.
  • Analysis of in vitro engineered models relevant to biomechanical stimulation.

Main Results:

  • Identified four main biomechanical traits: stretch, fluid shear stress, ECM microarchitecture, and ECM stiffness.
  • Classified these traits into static and dynamic categories pertinent to cardiac function.
  • Highlighted the impact of these traits on fibrosis and discussed transduction mechanisms.

Conclusions:

  • Biomechanical traits significantly influence cardiac fibrosis initiation, progression, and treatment.
  • In vitro models targeting biomechanical factors can aid in predicting mechano-based therapeutic targets.
  • Further research into mechanobiology offers potential for ameliorating cardiac fibrosis.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
30
Specialized Characteristics of Cardiac Muscles01:27

Specialized Characteristics of Cardiac Muscles

The primary role of cardiac muscles is to propel blood throughout the cardiovascular system. The cardiac muscle cells, or cardiomyocytes, exhibit specialized characteristics that allow them to perform this function.
Cardiac muscle cells are smaller than skeletal muscles, averaging 10–20 mm in diameter and 50–100 mm in length. However, they have large energy demands for continuous contraction and relaxation. This energy is almost exclusively derived from aerobic metabolism of energy...
2.7K
Structure of Cardiac Muscles01:13

Structure of Cardiac Muscles

Cardiac muscle, or myocardium, is a specialized type of muscle found exclusively in the heart. Its unique structural and functional characteristics enable the heart to perform its vital role of pumping blood throughout the body continuously and rhythmically. The cardiac muscle cells, or cardiomyocytes, possess an endomysium and perimysium but do not have an epimysium.
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
13.8K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
37
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.7K
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
766